Evidence map›Paper›PMID 32404173›Full record

Trial reportReproductive biology and endocrinology : RB&E2020

Effect of Letrozole on sperm parameters, chromatin status and ROS level in idiopathic Oligo/Astheno/Teratozoospermia.

Leila Kooshesh, Soghra Bahmanpour, Shahriar Zeighami, Mohammad Hussain Nasr-Esfahani

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Reproductive biology and endocrinology : RB&E, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Leila KoosheshDepartment of Anatomy, Shiraz University of Medical Sciences, Shiraz, Iran.
Soghra BahmanpourDepartment of Anatomy, Shiraz University of Medical Sciences, Shiraz, Iran.
Shahriar ZeighamiDepartment of Urology, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad Hussain Nasr-EsfahaniDepartment of Reproductive Biotechnology, Reproductive Biomedicine Research Centre, Royan Institute for Biotechnology, ACECR, Isfahan, Iran. mh.nasr-esfahani@royaninstitute.org.
Shiraz University of Medical Sciences · IRRoyan Institute · IR

Funding

Shiraz University of Medical Sciences 1396-01-01-15049
6 · The paper itself

Abstract

backgroundThis study investigates the effect of letrozole on hormone profiles, semen parameters, body mass index (BMI), degree of oxidative stress and sperm chromatin integrity in men with idiopathic oligo/astheno/teratozoospermia (iOAT) and T:E MATERIALS AND

methodsThis study is a longitudinal, prospective, interventional and open-labelled clinical trial. Semen samples were collected from 20 iOAT men with low serum testosterone (T) to estradiol (E

resultsSperm concentration, percentage of sperm motility and its normal morphology increased significantly after letrozole treatment. Moreover, serum testosterone level increased but estradiol level decreased significantly following treatment. The mean of T:E2 ratio improved 1600%. Also, letrozole treatment significantly reduced the percentage of sperm TUNEL positivity and sperm CMA3 positivity. While no significant difference was observed between intracellular ROS levels and BMI before and after treatment. Finally, as a notable result, four spontaneous pregnancies (20%) were achieved after treatment.

conclusionsLetrozole treatment can effectively increase spontaneous pregnancies by improving sperm parameters and sperm chromatin integrity in men with iOAT and T:E2 ratio ≤ 10.

trial registrationTrial registration: IRCT, IRCT20191030045283N1. Registered 16 November 2019 - Retrospectively registered, https://fa.irct.ir/user/trial/43484/view.

Indexed as

AdultAsthenozoospermiaChromatinDNA FragmentationHumansInfertility, MaleLetrozoleLongitudinal StudiesMaleOligospermiaOxidative StressReactive Oxygen SpeciesSemen AnalysisSpermatozoaSperm CountSperm MotilityChromatinLetrozoleReactive Oxygen SpeciesTestosteroneHormonal profileIdiopathic oligo/astheno/teratozoospermiaLetrozoleProtamine deficiencyROSSperm DNA fragmentation

Identifiers

PMID32404173
PMCPMC7218838
OpenAlexW3026693985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.